Amy is Founder and CEO of Juniper Point, Inc., where she leads the team as principal strategist and doer of all things. Amy is intimately involved with each client, providing round-the-clock advice, expertise and guidance in corporate communications, investor relations, media relations and overall corporate strategy.
Prior to founding Juniper Point, Amy spent 12 years as head of investor relations and corporate communications at San Diego biotech companies Anadys Pharmaceuticals (acquired by Roche in 2011) and Regulus Therapeutics (RGLS), acting as the primary Wall-Street facing leader and solidifying deep relationships with market-moving analysts, bankers and buy-siders. She has been involved in three IPOs, numerous follow-on transactions, pharma partnerships and one acquisition.
Amy is born and raised in California and has called San Diego home since 2003. She is passionate about the San Diego biotechnology ecosystem and where the community fits into the broader, global landscape. She has been a past president of the National Investor Relations Institute (NIRI) and is a frequent speaker on industry panels.
When she’s not working, you can find Amy on the basketball court, riding her bike, at the beach or playing with her son and dog Chili.